|
| Press Releases |
|
 |
|
| Monday, April 14, 2014 |
|
|
中国海淀收购英国手表公司 Dreyfuss |
| 拥有多个中国及全球著名手表品牌的钟表及时计产品设计、生产及零售商- 中国海淀集团有限公司（「中国海淀」或「集团」；股票代号：256）公布其全资附属公司国际飞迅有限公司与一间英国手表公司The Dreyfuss Group Limited（「Dreyfuss」）订立收购协议，收购Dreyfuss全部已发行股本。 more info >> |
|
|
中國海澱收購英國手錶公司 Dreyfuss |
| 擁有多個中國及全球著名手錶品牌的鐘錶及時計產品設計、生產及零售商 - 中國海澱集團有限公司（「中國海澱」或「集團」；股票代號：256）公佈其全資附屬公司國際飛迅有限公司與一間英國手錶公司The Dreyfuss Group Limited（「Dreyfuss」）訂立收購協議，收購Dreyfuss全部已發行股本。 more info >> |
|
|
China Haidian Acquires UK Watch Company Dreyfuss |
| China Haidian Holdings Limited ("China Haidian" or the "Group"; stock code: 256), a watches and timepieces designer, manufacturer and retailer owning several celebrated Chinese and global watch brands more info >> |
|
| Monday, March 24, 2014 |
|
|
China Haidian Announces 2013 Annual Results |
| China Haidian Holdings Limited (the "Group"; stock code: 256), a watches and timepieces designer, manufacturer and retailer owning several celebrated Chinese and global watch brands, announced its annual results for the financial year ended 31 December 2013. The Group achieved substantial revenue and profit growth in 2013. more info >> |
|
|
中国海淀公佈二零一三年全年业绩 |
拥有多个中国及全球著名手表品牌的钟表及时计产品设计、生产及零售商- 中国海淀集团有限公司（「集团」；股票代号：256）公布截至二零一三年十二月三十一日止财政年度的全年业绩。收入及溢利于二零一三年均大幅增长。
more info >> |
|
|
中國海澱公佈二零一三年全年業績 |
擁有多個中國及全球著名手錶品牌的鐘錶及時計產品設計、生產及零售商 - 中國海澱集團有限公司（「集團」；股票代號：256）公佈截至二零一三年十二月三十一日止財政年度的全年業績。收入及溢利於二零一三年均大幅增長。
more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
AdsDrama Launches Short-Drama Marketing Ecosystem Launch in the Dominican Republic, Paving the Way for Digital Content Innovation
Mar 14, 2026 05:00 HKT/SGT
|
|
|
General MRO Aerospace 取得中國民航局認證，拓展全球維修能力
Mar 13, 2026 22:20 HKT/SGT
|
|
|
General MRO Aerospace 获得中国民航局认证，拓展全球维护能力
Mar 13, 2026 22:20 HKT/SGT
|
|
|
General MRO Aerospace Achieves CAAC Certification, Expanding Global Maintenance Capabilities
Mar 13, 2026 22:20 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
Mar 13, 2026 22:00: JST
|
|
|
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
Mar 13, 2026 22:00 HKT/SGT
|
|
|
CITIC Resources Deepens Dual-Engine Strategy of 'Investment + Trading', Continues to Promote High-Quality Development
Mar 13, 2026 21:01 HKT/SGT
|
|
|
中信資源深化「投資+貿易」雙輪戰略 持續驅動高質量發展 推進「上游資產布局、貿易業務拓展、生產運營提質」
Mar 13, 2026 20:53 HKT/SGT
|
|
|
中信资源深化「投资+贸易」双轮战略 持续驱动高质量发展 推进「上游资产布局、贸易业务拓展、生产运营提质」
Mar 13, 2026 20:40 HKT/SGT
|
|
|
康哲藥業：腎性貧血新藥德昔度司他片中國獲批上市
Mar 13, 2026 20:24 HKT/SGT
|
|
|
康哲药业：肾性贫血新药德昔度司他片中国获批上市
Mar 13, 2026 20:15 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
Mar 13, 2026 18:00: JST
|
|
|
uSMART HK Expands to 12 Physical Service Centres in One Year, Accelerating "Online x Offline" O2O Community Finance Strategy
Mar 13, 2026 17:34 HKT/SGT
|
|
|
盈立證券一年拓展12個服務網點 全力深化「線上x線下」O2O社區金融佈局
Mar 13, 2026 17:21 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
Mar 13, 2026 17:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
